GO TO CMA Home
GO TO Inside CMA
GO TO Advocacy and Communications
GO TO Member Services
GO TO Publications
GO TO Professional Development
GO TO Clinical Resources

GO TO What's New
GO TO Contact CMA
GO TO Web Site Search
GO TO Web Site Map


CMAJ
CMAJ - May 30, 2000JAMC - le 30 mai 2000

Folic acid: the opportunity that still exists

Judith G. Hall

CMAJ 2000;162:1571-2

See also:
A woman's folic acid intake before conception and during early pregnancy plays a crucial role in preventing neural tube defects1,2 and has been associated with preventing other congenital abnormalities as well.3 Health agencies and professional societies concerned with obstetrics and children's health have recommended that all women of childbearing age take a daily supplement of folic acid,4–6 especially because 50% of pregnancies in North America are mistimed or unplanned. However, studies7–9 have found that less than 30% of women who attend their first prenatal clinic have taken extra folic acid before conception or early in pregnancy when the neural tube closes (i.e., 2 weeks after the first missed menstrual period). Moreover, James House and colleagues10 (see page 1557 in this issue) report that 5 years after this important information about folate's protective effects became available and recommendations were broadly publicized, more than 25% of women in Newfoundland who attended their first prenatal clinic had serum folate levels that were low enough to be of concern.

At least 5% of babies are born with some serious congenital anomaly.11 Although publicity to increase awareness and prevent birth defects has focused on folic acid intake and neural tube defects, several studies suggest that taking multivitamins containing folic acid during the periconceptional period can reduce the risk of other conditions such as congenital heart defects,3,12–14 urinary tract anomalies,14,15 orofacial clefts,3,16–18 limb defects12 and pyloric stenosis.3 It is estimated that as many as half of all birth defects can be prevented if women of childbearing age consume an adequate amount of folic acid, either by eating sufficient foods that are fortified with folic acid or by taking vitamin supplements.19

Despite attempts to increase public awareness, by the mid-1990s it became clear that many women were not changing their eating habits, nor were they taking vitamin supplements before conception. One way to increase folic acid intake without relying on a change in behaviour is to add it to foods that are normally consumed. In 1998 Canada followed the American lead by allowing fortification of enriched grain products with what would increase intake by about 100 µg of folic acid a day. Given that the average North American diet provides 200 µg of folic acid per day, the addition of 100 µg would bring the average daily intake to about 300 µg. However, studies suggest that a daily intake of 400 µg (0.4 mg) may be required to reduce the risk of birth defects,20 and many people consume less than 200 µg daily because they do not eat (or perhaps cannot afford) enough of the vegetables and fruits that are high in folic acid — witness the 25% of pregnant women in Newfoundland surveyed by House and colleagues.10

In Canada folic acid fortification of enriched grains is not mandatory; rather, it is permitted21 so that we can be commercially compatible with the United States. The failure to date to add adequate amounts of folic acid to the grain chain is linked to a possible problem with B12 deficiency. It is estimated that up to 5% of elderly adults are B12 deficient, and in these people large doses of folic acid could mask the anemia associated with B12 deficiency and lead to possible neurologic damage.22

In addition to preventing neural tube defects, folic acid also likely plays an important role in reducing the risk of cardiovascular disease, including coronary artery disease, stroke and peripheral vascular disease,23–26 and in reducing the risk of cancer.19,27,28 Folate is also needed to make DNA, required for growth, repair and an adequate immune response. Thus, grain fortification is beneficial not only for embryonic and fetal development but also for important metabolic processes in people of all ages.

It is likely that 100 000 years ago our ancestors ate 14–16 servings of fresh fruits and vegetables (the major natural source of folate) each day. Folate is, however, heat labile, so with cooking and our modern diets very few people consume the amounts of fruits and vegetables that our bodies have evolved to expect. Consequently, we are all at risk of inadequate folic acid intake through diet alone.

Why are we not taking every opportunity to stay healthy — to provide our bodies with all the tools necessary to function properly? More importantly, why are some of us not giving the children of tomorrow every opportunity to grow normally and reach their full potential? Perhaps because we are inundated every day with so much information about nutrition and the supplements we should take, information that seems to change monthly. It is little wonder that we have become bored with it all and pay little attention. However, the folic acid story has not changed and is not boring — it has only become more compelling. We would all benefit from a supplement of 400 µg of folic acid a day, alone or in a multivitamin. We do not need megadoses, but it is clear that our bodies and those of developing babies need adequate amounts of folic acid to function normally.

The knowledge we have gained in studies on folic acid should be seen as a public health opportunity29,30 and an opportunity for every individual. The report on women from Newfoundland10 suggests that at least 25% of the population, and I suspect a similar percentage in the other provinces, is missing the opportunity to be fully healthy. While we await further data, it behooves us all to ensure we are getting enough folic acid — as children for normal growth, as young women to prevent birth defects and as adults of all ages to reduce the risk of cardiovascular disease and cancer. All Canadians can benefit.

Competing interests: None declared.

Comments Send a letter to the editor
Envoyez une lettre à la rédaction

Dr. Hall is Professor and Head, Department of Pediatrics, University of British Columbia and British Columbia's Children's Hospital, Vancouver, BC.

Correspondence to: Dr. Judith G. Hall, Professor and Head, Department of Pediatrics, University of British Columbia and British Columbia's Children's Hospital, 4480 Oak St., Rm 2D15, Vancouver BC V6H 3V4; fax 604 875-2969; jhall@cw.bc.ca

References
  1. Medical Research Council Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-7. [MEDLINE]
  2. Czeizel AE, Dudas L. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5. [MEDLINE]
  3. Czeizel AE. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ 1993;306:1645-8. [MEDLINE]
  4. Centers for Disease Control. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects: MMWR 1992;41:1-8.
  5. Committee on Genetics. Folic acid for the prevention of neural tube defects. Pediatrics 1993;92:493-4. [MEDLINE]
  6. Canadian Pediatric Society. Periconceptional use of folic acid and reduction of the risk of neural tube defects. CPS Statement. DT95-01, 1995:1-4.
  7. Knowledge and use of folic acid by women of childbearing age — United States, 1997. MMWR 1997;46:721-3.
  8. Knowledge and use of folic acid by women of childbearing age — United States, 1995. MMWR 1995;44:716-8.
  9. Bonin MM, Bretzlaff JA, Therrien SA, Rowe BH. Knowledge of periconceptional folic acid for the prevention of neural tube defects. The missing links. Northeastern Ontario Primary Care Research Group. Arch Fam Med 1998;7:438-42. [MEDLINE]
  10. House JD, March SB, Ratnam S, Ives E, Brosnan JT, Friel JT. Folate and vitamin B12 status of women in Newfoundland at their first prenatal visit. CMAJ 2000;162(11):1557-9.
  11. Chung CS, Myrianthopoulos NC. Congenital anomalies: mortality and morbidity, burden and classification. Am J Med Gen 1987;27:505-23.
  12. Shaw GM, O'Malley CD, Wasserman CR, Tolarova MM, Lammer EJ. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 1995;59:536-45. [MEDLINE]
  13. Botto LD, Khoury MJ, Mulinara J, Erickson JD. Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case–control study. Pediatrics 1996;98:911-7. [MEDLINE]
  14. Czeizel AE. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 1996;62:179-83. [MEDLINE]
  15. Li DK, Daling JR, Mueller BA, Hickok DE, Fantel AG, Weiss NS. Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiology 1995;6:212-8. [MEDLINE]
  16. Hayes C, Werler MM, Willett WC, Mitchell AA. Case–control study of periconceptional folic acid supplementation and oral clefts. Am J Epidemiol 1996;143:1229-34. [MEDLINE]
  17. Shaw GM, Lammer EJ, Wasserman CR, O'Malley CD, Tolarova MM. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 1995;345:393-6.
  18. Tolarova M, Harris J. Reduced recurrence of orofacial clefts after periconceptional supplementation with high-dose folic acid and multivitamins. Teratology 1995;51:71-8. [MEDLINE]
  19. Hall JG, Solehdin F. Folate and its various ramifications. Adv Pediatr 1998;45:1-35. [MEDLINE]
  20. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, et al. Prevention of neural-tube defects with folic acid in China. N Engl J Med 1999;341:1485-90. [MEDLINE]
  21. Turner LA, McCourt C. Folic acid fortification: What does it mean for patients and physicians? CMAJ 1998;158:773-4. [MEDLINE]
  22. Tucker KL, Mahnken B, Wilson PWF, Jacques P, Jacob S. Folic acid fortification of the food supply. Potential risks and benefits for the elderly population. JAMA 1996;276:1879-85. [MEDLINE]
  23. Omenn GS, Beresford SA, Motulsky AG. Preventing coronary heart disease: B vitamins and homocysteine. Circulation 1998;97:421-4. [MEDLINE]
  24. Oakley GP Jr. Eat right and take a vitamin [editorial]. N Engl J Med 1998;338:1060-1. [MEDLINE]
  25. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042-50. [MEDLINE]
  26. McCully KS. Homocysteine and vascular disease. Nat Med 1996;2:386-9. [MEDLINE]
  27. Report of the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, other B Vitamins, and Choline and Subcommittee on Upper Reference Levels of Nutrients, Institute of Medicine. Folate. In: Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline (Institute of Medicine prepublication copy). Washington: National Academy Press; 1998. p. 8-1-8-68.
  28. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997;57:1098-102. [MEDLINE]
  29. Oakley GP Jr. Prevention of neural-tube defects [letter]. N Engl J Med 1999;341:1547. [MEDLINE]
  30. Meyer RE, Oakley GP Jr. Folic acid fortification [letter]. Lancet 1999;354:2168. [MEDLINE]

© 2000 Canadian Medical Association or its licensors